A detailed history of Acas, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Acas, LLC holds 14,987 shares of PFE stock, worth $395,057. This represents 0.37% of its overall portfolio holdings.

Number of Shares
14,987
Previous 14,987 -0.0%
Holding current value
$395,057
Previous $419,000 3.34%
% of portfolio
0.37%
Previous 0.39%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

SELL
$25.89 - $29.73 $18,304 - $21,019
-707 Reduced 4.5%
14,987 $415,000
Q4 2023

Feb 01, 2024

SELL
$26.13 - $33.94 $25,084 - $32,582
-960 Reduced 5.76%
15,694 $451,000
Q3 2023

Oct 24, 2023

SELL
$32.09 - $37.51 $6,097 - $7,126
-190 Reduced 1.13%
16,654 $552,000
Q2 2023

Jul 26, 2023

SELL
$36.12 - $41.79 $5,779 - $6,686
-160 Reduced 0.94%
16,844 $617,000
Q1 2023

Apr 21, 2023

BUY
$39.39 - $51.28 $84,530 - $110,046
2,146 Added 14.44%
17,004 $693,000
Q2 2022

Aug 01, 2022

SELL
$46.53 - $55.17 $1,163 - $1,379
-25 Reduced 0.17%
14,858 $750,000
Q1 2022

Apr 28, 2022

SELL
$45.75 - $56.69 $183,000 - $226,760
-4,000 Reduced 21.18%
14,883 $770,000
Q4 2021

Jan 31, 2022

BUY
$41.32 - $61.25 $780,245 - $1.16 Million
18,883 New
18,883 $1.09 Million
Q4 2021

Jan 19, 2022

SELL
$41.32 - $61.25 $617,031 - $914,646
-14,933 Closed
0 $0
Q3 2021

Oct 19, 2021

SELL
$39.25 - $50.42 $24,374 - $31,310
-621 Reduced 3.99%
14,933 $642,000
Q2 2021

Jul 14, 2021

SELL
$35.91 - $40.68 $136,996 - $155,194
-3,815 Reduced 19.7%
15,554 $609,000
Q1 2021

May 04, 2021

BUY
$33.49 - $37.77 $648,667 - $731,567
19,369 New
19,369 $576,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Acas, LLC Portfolio

Follow Acas, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acas, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acas, LLC with notifications on news.